Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr₹-1,506 Cr₹-1,439 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹-1,049 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-1,049 Cr
Mar2023₹-1,805 Cr
Mar2022₹-1,655 Cr
Mar2021₹-1,506 Cr
Mar2020₹-1,439 Cr

How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-1,049 Cr
Negative
Mar2023 ₹-1,805 Cr
Negative
Mar2022 ₹-1,655 Cr
Negative
Mar2021 ₹-1,506 Cr
Negative
Mar2020 ₹-1,439 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,621.2 Cr -2% 33.4% 57.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr -2.1% 1.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -1.5% 1.5% 46.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 2.5% 11.2% 15.3% Stock Analytics
CIPLA ₹119,184.0 Cr -1% -1.7% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr -0.1% -5% -5.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2%

33.4%

57.6%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses